The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.
The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...
Chronic low back pain can disrupt your daily life, keeping you from enjoying family moments, outdoor adventures or even simple tasks like walking or sitting comfortably. If traditional treatments ...
The FDA has approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid ...